Can Nanotech or Bacteria Provide a Cure for Ebola?

Click For Summary
SUMMARY

The discussion centers on the potential of genetically engineered bacteria and nanotechnology to combat Ebola virus disease (EVD). Participants highlight the emerging field of nanomedicine, noting its nascent stage in addressing viral infections like Ebola. While there have been advancements in using nanotechnology for cancer treatment, effective therapies for Ebola remain in development. The complexity of viral mechanisms and high mutation rates complicate the creation of universal antiviral treatments, necessitating innovative approaches such as interferon therapy.

PREREQUISITES
  • Understanding of nanomedicine and its applications in viral treatment.
  • Knowledge of viral replication mechanisms and mutation rates.
  • Familiarity with antiviral strategies, including the use of interferon.
  • Awareness of the challenges in developing cures for complex viruses like Ebola.
NEXT STEPS
  • Research the latest advancements in nanomedicine for viral infections.
  • Explore the mechanisms of viral mutation and resistance development.
  • Investigate interferon treatments and their efficacy against various viruses.
  • Study the challenges in creating broad-spectrum antiviral therapies.
USEFUL FOR

Researchers, virologists, and healthcare professionals interested in the intersection of nanotechnology and viral disease treatment, particularly those focused on Ebola and other complex viral infections.

Syed Ammar
Messages
25
Reaction score
1
I was just wondering if some bacteria or nanotechnology could be genetically engineered to target the Ebola strains? Is this possible?
If it is then why is no one coming up with a cure?
 
Biology news on Phys.org
Syed Ammar said:
If it is then why is no one coming up with a cure?

You can be sure they are hard at work. Trick is, it is never as easy as snapping your fingers.
 
Syed Ammar said:
I was just wondering if some bacteria or nanotechnology could be genetically engineered to target the Ebola strains? Is this possible?

How would that work? Are there existing treatments that use bacteria or nanotechnology to combat viruses?
 
Why is not the answer about curing Ebola EVD the same as for polio or HIV ( each of which has many more victims and a much longer time to develop a cure - which is not a vaccine )?
 
I guess others will give a more detailed answer, but basically there are many different viruses which use different techniques when attacking cells/reproducing, so what works against one, doesn't have to work against another.
 
Doug Huffman said:
Why is not the answer about curing Ebola EVD the same as for polio or HIV ( each of which has many more victims and a much longer time to develop a cure - which is not a vaccine )?
Not sure what you are saying there. There is no "cure" for polio or HIV.
Polio eradication is through administration of vaccine(s), so that the body prohibits the polio virus that enters the gut from infecting tissue.

HIV treatment is administration of a cocktail of drugs that keep the virus responsible for the disease in check.
 
What ALL viruses have in common is the lack of 'machinery' with which to reproduce. That said, there are only about a dozen virus families, of 5000-ish known, that sicken humans.

Borek said:
I guess others will give a more detailed answer, but basically there are many different viruses which use different techniques when attacking cells/reproducing, so what works against one, doesn't have to work against another.
 
Doug Huffman said:
What ALL viruses have in common is the lack of 'machinery' with which to reproduce. That said, there are only about a dozen virus families, of 5000-ish known, that sicken humans.

How is it related to what I wrote?
 
  • #10
Doug Huffman said:
What ALL viruses have in common is the lack of 'machinery' with which to reproduce.

Yes but that's not in of itself a target, there's no real difference between viral mRNA and human mRNA. Instead anti-virals have to target any number of processes that can be very different e.g. anti-retrovirals can target viral reverse transcriptase to prevent DNA formation. This will be useless against adenoviruses. Other targets include entry into the cell and viral genome incorporation amongst others, both of which differ for different species.

On top of this viruses mutate at an incredibly high rate making them annoyingly good at developing resistance. To get around this I believe anti-virals (like HIV medication) targets multiple different things at once.
 
  • #11
Ryan_m_b said:
Yes but that's not in of itself a target, there's no real difference between viral mRNA and human mRNA. Instead anti-virals have to target any number of processes that can be very different e.g. anti-retrovirals can target viral reverse transcriptase to prevent DNA formation. This will be useless against adenoviruses. Other targets include entry into the cell and viral genome incorporation amongst others, both of which differ for different species.

That said, there are some creative ideas for therapies that could act against a broader spectrum of viruses. A simple example is interferon treatment which can be helpful against a number of viruses because it helps boost the immune system's antiviral defenses. Some of these antiviral defenses detect viral infection by scanning for long segments of double-stranded RNA which often occur as intermediates in the replication of RNA viruses, but are mostly absent in uninfected cells. Researchers have engineered some of these proteins to create treatments that could potentially target a broad spectrum of RNA viruses (see this previous PF thread for further discussion). Of course, the paper I cite above is a simple proof-of-concept experiment, and it is still unclear whether the treatment would work in humans. Still, it is an intriguing idea.
 
  • #12
Ygggdrasil said:
That said, there are some creative ideas for therapies that could act against a broader spectrum of viruses. A simple example is interferon treatment which can be helpful against a number of viruses because it helps boost the immune system's antiviral defenses. Some of these antiviral defenses detect viral infection by scanning for long segments of double-stranded RNA which often occur as intermediates in the replication of RNA viruses, but are mostly absent in uninfected cells. Researchers have engineered some of these proteins to create treatments that could potentially target a broad spectrum of RNA viruses (see this previous PF thread for further discussion). Of course, the paper I cite above is a simple proof-of-concept experiment, and it is still unclear whether the treatment would work in humans. Still, it is an intriguing idea.

Quite true, though as promising as DRACOs are as far as I'm aware none have reached market yet.
 
  • #13
Borek said:
You can be sure they are hard at work. Trick is, it is never as easy as snapping your fingers.
Oh! Ok :(
 

Similar threads

  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 18 ·
Replies
18
Views
6K
Replies
1
Views
2K
  • · Replies 20 ·
Replies
20
Views
3K
  • · Replies 5 ·
Replies
5
Views
4K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 3 ·
Replies
3
Views
5K
Replies
8
Views
5K
  • · Replies 3 ·
Replies
3
Views
3K
  • · Replies 8 ·
Replies
8
Views
5K